U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
Go back to U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY| Harmony Metals, Inc. Common (NASDAQ: HRMY) | Delayed: 33.62 +0.34 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.28 | 52 Week High | $1.35 | |||
| Open | $33.46 | 52 Week Low | $0.10 | |||
| Day High | $33.80 | P/E | N/A | |||
| Day Low | $33.10 | EPS | $0.00 | |||
| Volume | 299,089 | |||||
